Leigh MacMillan Archive — Page 48 of 85

October 13, 2017

New tools to combat kidney fibrosis

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

A researcher in a white lab coat sits in a laboratory, with shelves of supplies and scientific equipment behind him.
October 12, 2017

Researcher targets peanut allergies with Cohen Fund support

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith’s research could fundamentally change allergy treatment.

Transparent graduated laboratory pipette resting across multiple clear culture dishes containing pink-purple liquid.
October 4, 2017

Boosting sarcoma cell death

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.

Blue-toned scientific illustration of intertwined DNA double helices with molecular structures in the foreground and background.
September 29, 2017

Novel insights to antibiotic targets

New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines.

Illustration of overlapping purple spherical cells, each with a prominent blue spherical nucleus, against a black background.
September 28, 2017

Cellular calcium handling in diabetes

Potassium channels in a cellular organelle regulate calcium flux and appear to play a critical role in pancreatic beta cell health.

Three women stand at a table in a lecture hall; the center woman signs a poster while the others look on. Audience members sit in the background.
September 28, 2017

VU scientists discuss cancer treatments, cellular dynamics

A trio of Vanderbilt University scientists described their cutting-edge investigations of cellular dynamics and cancer treatment during last week’s Flexner Discovery Lecture.